Application of PDCA Cycle Management in Monitoring ADR in Hospital

Wei Lingyu, Qiu Xiaochun, Zhou Yanlai, Wang Zuorong

Chinese Pharmaceutical Affairs ›› 2017, Vol. 31 ›› Issue (6) : 703-710.

Chinese Pharmaceutical Affairs ›› 2017, Vol. 31 ›› Issue (6) : 703-710. DOI: 10.16153/j.1002-7777.2017.06.022
Adverse Reaction

Application of PDCA Cycle Management in Monitoring ADR in Hospital

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 31(6): 703-710 https://doi.org/10.16153/j.1002-7777.2017.06.022

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉